Obesity: Clinical Trials

13,174 trials for Obesity, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8165 completed, 1634 unknown, 1314 recruiting, 589 active not recruiting. 7702 Not applicable, 932 Phase 2, 748 Phase 1, 652 Phase 3, 568 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable7702Completed 4981, Unknown 958, Recruiting 683, Active not recruiting 326, Not yet recruiting 281, Terminated 249, Withdrawn 151, Enrolling by invitation 62, Suspended 11
Phase 2932Completed 572, Recruiting 98, Unknown 64, Terminated 58, Active not recruiting 57, Not yet recruiting 40, Withdrawn 36, Enrolling by invitation 4, Suspended 3
Phase 1748Completed 481, Recruiting 107, Active not recruiting 45, Not yet recruiting 36, Terminated 30, Unknown 30, Withdrawn 17, Enrolling by invitation 1, Suspended 1
Phase 3652Completed 362, Recruiting 86, Unknown 58, Terminated 46, Active not recruiting 43, Not yet recruiting 38, Withdrawn 16, Suspended 2, Enrolling by invitation 1
Phase 4568Completed 322, Unknown 80, Recruiting 47, Not yet recruiting 38, Terminated 32, Active not recruiting 24, Withdrawn 20, Enrolling by invitation 4, Suspended 1
Early Phase 1118Completed 61, Unknown 15, Recruiting 13, Withdrawn 9, Active not recruiting 6, Not yet recruiting 5, Terminated 5, Suspended 3, Enrolling by invitation 1

Follow Obesity: new trials by email Literature Review of Obesity trials Research Report on Obesity

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluating the Metabolic Effects of Polylactose: A Novel Prebiotic
Polylactose, Placebo - Obesity, Adolescent, Obesity, Childhood
Not applicableWithdrawnUniversity of Minnesota2028-05-012025-07-11
A Study of Body Fat Distribution and Airway Mechanics in Healthy Adults
Body positioning - Healthy Volunteers Only
Not applicableNot yet recruitingMaurizio F. Cereda, MD202028-01-012025-06-18
Adiposity Distribution in Acute Respiratory Failure
PEEP Titration Using Electrical Impedance Tomography (EIT), Body Positioning: Supine and Prone - Acute Hypoxemic Respiratory Failure, Obesity
Not applicableNot yet recruitingMaurizio F. Cereda, MD802028-01-012025-06-13
Community Active and Healthy Families Pragmatic Trial
Community Active and Healthy Families Intensive Health Behavior and Lifestyle Treatment - Child Obesity
Phase 4Not yet recruitingUniversity of Colorado, Denver4162028-01-012026-10-09
AI-INFORMED PEER-MENTORING BEHAVIORAL INTERVENTION FOR OBESITY AND CARDIOVASCULAR DISEASE PRIMARY PREVENTION IN YOUTH
AI-informed behavioral intervention, Standard behavioral intervention, Health Education - Obesity (Disorder)
Not applicableNot yet recruitingAikaterini Karaivazoglou8402027-09-012026-04-14
Modifying Diet to Improve Gut Microbiome
DASH diet, standard American diet - Obesity
Not applicableNot yet recruitingH. Lee Moffitt Cancer Center and Research Institute282027-07-012026-09-17
Simplifying Diet Tracking in a Digital Weight Loss Intervention
Simplified Dietary Self-Monitoring, Detailed Dietary Self-Monitoring, Core Behavioral Weight Loss Intervention - Overweight, Obesity
Not applicableNot yet recruitingStanford University3282027-05-012026-05-28
Impact of Endoscopic Sleeve Gastroplasty (ESG) in Obese Adults With Type 2 Diabetes (T2D)
ESG with OverStitch - Type 2 Diabetes Mellitus (T2D), Obesity (BMI>30)
Not applicableNot yet recruitingBoston Scientific Corporation502027-04-012026-10-23
Can Two Dietary Interventions Maintain Weight Loss for 12 Months After GLP-1 Therapy in Adults With Overweight/Obesity?
NutriAct plus, Rescue VLCD - Obesity & Overweight, Weight Loss Maintenance
Not applicableNot yet recruitingKnut Mai2922027-03-012026-07-20
Cardiometabolic Effects of the Recommended Daily Pecan Intake Dose
Pecan, Control - Nutrition, Healthy, Dyslipidemia
Not applicableNot yet recruitingUniversity of Georgia902027-03-012026-08-11
Evaluating the Efficacy and Safety of LUM-201 Plus Semaglutide Versus Semaglutide Plus Placebo in Older Obese Adults
LUM-201, Placebo, Semagludtide - Obesity & Overweight
Phase 2Not yet recruitingLumos Pharma2022027-02-152026-08-10
BRE-13: Mediterranean Diet
Explore the effect of MedDiet vs. Usual Diet on Fatty Acid Profile, Explore the effect of MedDiet vs. Usual Diet on Breast Tumor Tissue, Explore the effect of MedDiet vs. Usual Diet on Lipids - Dietary Assessment, Dietary and Lifestyle Behaviour Change
Not applicableNot yet recruitingUniversity of Illinois at Chicago302027-02-152026-10-09
Effects of Tirzepatide on Gut Microbiota and Gastrointestinal Function After Drug Withdrawal in Obese Patients
Tirzepatide - Obesity / Overweight
Not yet recruitingNanjing First Hospital, Nanjing Medical University802027-02-012026-10-15
Semaglutide for Low Back Pain
Semaglutide (administered by PDS290 pen-injector), Placebo (administered by PDS290 pen-injector) - Lower Back Pain, Obesity (BMI>30)
Phase 2Not yet recruitingWashington University School of Medicine2502027-02-012026-07-28
EMBodied psychOsocial Impacts of Weight Stigma During Pregnancy (EMBODY): A Prospective Cohort Study
Weight Stigma, Pregnancy Outcomes
Not yet recruitingMonash University8002027-02-012026-10-16
Prospective Study of an Explainable AI Tool to Support Biliopancreatic Limb Selection in One-Anastomosis Gastric Bypass
One-anastomosis gastric bypass with observed biliopancreatic limb length - Obesity, Severe Obesity
Not yet recruitingThe Society of Bariatric and Metabolic Surgeons of Kazakhstan1202027-01-152026-09-14
AMAZE 13: A Research Study Investigating How Well the Medicine Zenagamtide Helps People in Asia With Excess Body Weight Lose Weight
Zenagamtide, Placebo ( matched to Zenagamtide) - Obesity, Overweight
Phase 3Not yet recruitingNovo Nordisk A/S4002027-01-072026-08-24
Target Physiotherapy Versus Exercise Support Intervention for Bladder-bowel Dysfunction in Adolescents With Obesity
Target physiotherapy, Exercise support intervention, Usual obesity care - Bladder-Bowel Dysfunction, Obesity & Overweight
Not applicableNot yet recruitingUniversity of Lisbon2372027-01-042026-07-23
Addressing Food Access and Physical Activity to Improve Diabetes Prevention Outcomes Among Underserved African Americans
Culturally-tailored, enhanced adaption of Diabetes Prevention Program - Diabetes, Physical Activity
Not applicableNot yet recruitingUniversity of Missouri, Kansas City4082027-01-042026-06-09
Patient-centred Intervention With Virtual Support for Obesity and Kidney Transplant Access
Semaglutide, Virtual Weight Management Coaching - Obesity, Chronic Kidney Disease
Phase 4Not yet recruitingKristin Clemens8802027-01-012026-10-05

Showing 20 of 13174. Sign in to see all of them.

Narrower conditions

Overweight (3043)  ·  Weight Loss (1170)  ·  Pediatric Obesity (1121)  ·  Motor Activity (1109)  ·  Diabetes Mellitus, Type 2 (1075)  ·  Obesity, Morbid (931)  ·  Diabetes Mellitus (803)  ·  Insulin Resistance (751)  ·  Metabolic Syndrome (699)  ·  Hypertension (571)  ·  Cardiovascular Diseases (470)  ·  Inflammation (308)  ·  Obesity, Abdominal (289)  ·  Body Weight (285)

Broader conditions

Nutritional and Metabolic Diseases (13154)  ·  Overnutrition (13135)  ·  Nutrition Disorders (13072)  ·  Pathological Conditions, Signs and Symptoms (13052)  ·  Signs and Symptoms (13017)  ·  Body Weight (12721)  ·  Overweight (10131)  ·  Metabolic Diseases (3138)  ·  Glucose Metabolism Disorders (2964)  ·  Endocrine System Diseases (2157)  ·  Behavior (2015)  ·  Hyperinsulinism (1305)  ·  Body Weight Changes (1299)  ·  Diabetes Mellitus (1179)

Interventions

Exercise (476)  ·  Diet (231)  ·  semaglutide (216)  ·  Bariatric Surgery (163)  ·  Tirzepatide (143)  ·  Liraglutide (121)  ·  Metformin (117)  ·  Gastric Bypass (116)  ·  Caloric Restriction (105)  ·  Nutrition Assessment (95)  ·  Control Groups (85)  ·  Resistance Training (79)  ·  Diet Therapy (77)  ·  Sodium Chloride (72)  ·  Standard of Care (71)

Sponsors

Novo Nordisk A/S (204)  ·  University of Colorado, Denver (117)  ·  Eli Lilly and Company (116)  ·  Mayo Clinic (111)  ·  National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (103)  ·  The Miriam Hospital (90)  ·  Washington University School of Medicine (89)  ·  Pennington Biomedical Research Center (88)  ·  University of Copenhagen (85)  ·  Maastricht University Medical Center (84)  ·  University of Alabama at Birmingham (84)  ·  Massachusetts General Hospital (82)  ·  Yale University (81)  ·  Duke University (80)  ·  University of Pennsylvania (79)

Countries

United States (5403)  ·  Canada (629)  ·  China (613)  ·  France (561)  ·  United Kingdom (493)  ·  Spain (455)  ·  Turkey (Türkiye) (425)  ·  Italy (392)  ·  Denmark (382)  ·  Germany (355)  ·  Brazil (315)  ·  Netherlands (278)  ·  Mexico (233)  ·  Egypt (221)  ·  Sweden (219)

Top investigators

Samuel Klein, MD (22)  ·  Jack A Yanovski, M.D. (20)

Results publications

PMID 38375882, PMID 33512717, PMID 29718281, PMID 38376518, PMID 26210388, PMID 30122305, PMID 26708836, PMID 28386912, PMID 28950422, PMID 30230252, PMID 30651576, PMID 33238176, PMID 33782940, PMID 38271099, PMID 40839263, PMID 41029405, PMID 42014131, PMID 22085317, PMID 23987123, PMID 24500151, PMID 26599819, PMID 27482610, PMID 27817208, PMID 28473337, PMID 31004409, PMID 32002540, PMID 32909523, PMID 33567185, PMID 37652841, PMID 38698650, PMID 39226070, PMID 39952695, PMID 40705619, PMID 11832527, PMID 15479938, PMID 17715408, PMID 18673303, PMID 19858703, PMID 20573639, PMID 21932999, PMID 22963820, PMID 23661689, PMID 23703580, PMID 24570244, PMID 24586896, PMID 25343235, PMID 26132939, PMID 26418188, PMID 26589105, PMID 26609668

NIH funding

2025 (54), 2023 (36), 2017 (26), 2019 (22), 2018 (16), 2014 (15), 2015 (15), 2016 (14), 2009 (13), 2008 (10), UL1TR001082 (9), P50MD017338 (6), R01DK059853 (6), UL1TR000135 (6), 2005 (5)